The American Journal of Hypertension 1

The American Journal of Hypertension 1

FC1 - Free Communications 1

Effects of Combined Metformin, Glibenclamide and Honey Supplementation on Free Radical Scavenging Enzymes and Lipid Peroxidation in

Pancreas of Streptozotocin-Induced Diabetic Rats

O.O. Erejuwa 1, S.A. Sulaiman 1, M.S. Ab Wahab 1, K.N.S. Sirajudeen 2, S. Salzihan 3

1 Department of Pharmacology, 2 Department of Chemical Pathology, 3 Department of Pathology, School of Medical Sciences, University Sains Malaysia, Kubang Kerian,

Kelantan, Malaysia

The 2nd International Conference on Fixed Combination in the Treatment of Hypertension 1-1


Effects of Zinc and Vitamin A Supplementation on Serum Fasting Blood Sugar, Insulin, Apoprotein B and Apoprotein A-I in Patients with Type I Diabetes

F. Shidfar 1, M. Aghasi 1, M. Vafa 1, I. Heydari 2

1 Nutrition, Human Nutrition, School of Health, Iran University of Medical Sciences and GILDRC, 2 Internal Medicine, Endocrinology, Iran University of Medical Sciences, Tehran,

Iran



The Effect of Adding Non-Pharmacologic Treatment to Standard Antihypertensive Drug Regimen in Treated but

Uncontrolled Hypertensive Patients

E. Paran 1, Y. Sharoni 2, Y. Levi 2, V. Novack 1

1 Hypertension Unit, Medicine, Soroka University Hospital, 2 Department of Clinical Biochemistry, Ben-Gurion University of the Negev, Beer- Sheva, Israel



Persistence of Combination Therapy among 29,253 Chinese Patients: A Population-Based Cohort Study

M. Wong, J. Jiang, S. GriffithsSchool of Public Health, Family Medicine and Primary Care, Chinese University of Hong

Kong, Hong Kong, HKSAR, China


BasedOn Template.indd 1 8/19/2009 5:42:21 PM

Dow

nloaded from https://academ

ic.oup.com/ajh/article/22/S1/1/92569 by guest on 25 Septem

ber 2022

2 The American Journal of Hypertension


Evaluate the Effect of Statin/Fibrate Combination Therapy on Increasing the Risk of Myositis in Patients With Diabetes

B. SaberiMedical College of Najafabad, Azad University, Azad, Iran


S01 - Symposium 1

History of Fixed Combination

T. Rosenthal 1, I. Gavras 2

1 Department of Physiology and Pharmacology, Hypertension Research Unit, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, 2 Hypertension and Atherosclerosis

Section, Boston University School of Medicine, Boston, MA, USA


S01 - Symposium 1

Fixed Combination Therapy: Pluses and Minuses

M.H. AldermanDepartment of Epidemiology & Population Health, Albert Einstein College of Medicine, New

York, NY, USA


S02 - Symposium 2

Position of the Guidelines for Antihypertensive Treatment about FDC

G. ManciaDepartment of Clinical Medicine, Prevention and Applied Biotechnologies, University of

Milan-Bicocca, Milan, Italy



Dow



ber 2022


S02 - Symposium 2

Treatment of Resistant Hypertension

S. Oparil, M.C. AcelajadoDivision of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham,

AL, USA


S02 - Symposium 2

Impact of Different Fixed Drug Combinations in the 24-Hour Blood Pressure Circadian Profile

M. BursztynMedicine, Hadassah-Hebrew University Medical Center, Mount-Scopus, Jerusalem, Israel


S02 - Symposium 2

ABPM to Refine the Risk Assessment in Hypertension

C. FarsangSt. Imre Teaching Hospital, Cardiometabolic Centre, Budapest, Hungary


S03 - Symposium 3

Has the Time Come for a Fixed Combination of Renin Inhibitor with ACEI or ARB?

H. GavrasMedicine, Hypertension and Atherosclerosis, Boston University School of Medicine, Boston,

MA, USA



Dow



ber 2022


S03 - Symposium 3

Beneficial Impact of Treating Blood Pressure and Cholesterol Together

P. SeverInternational Centre for Circulatory Health, Imperial College London, London, UK



Any-Cause Hospitalization Outcomes Associated with Poor Patient Adherence to Antihypertensives

J. LaFleur 1,2, R. Nelson 1,2, B. Sauer 2,3, X. Sheng 4, S. Pickard 2, S.H. Ong 5, D. Brixner 1,J. Nebeker 2,3

1 Pharmacotherapy, University of Utah College of Pharmacy, Salt Lake City, Utah, USA, 2 IDEAS Center, Veterans Affairs Health Care System, Salt Lake City, Utah, USA,

3 Internal Medicine, Clinical Epidemiology, University of Utah School of Medicine, Salt Lake City, Utah, USA, 4 Pediatrics, University of Utah School of Medicine, Salt Lake City,

Utah, USA, 5 Global Health Economics and Outcomes Research, Novartis Pharma AG, Bazel, Switzerland



The Beneficial Effect of Eprosartan and Amiodarone on Atrial Fibrillation Recurrence in Hypertensive Patients

K. Adamyan, L. Hazarapetyan, S. GrigoryanArrhythmia, Cardiology, National Institute of Health, Yerevan, Armenia



Differences Between Olmesartan/Amlodipine and Olmesartan/Thiazide Combinations on Central Arterial Pressure and Augmentation Index

A. Otohima, S. Nishihara, M. NakamuraHypertension Research, Cardiology, Fukuoka University Hospital, Fukuoka, Japan



Dow



ber 2022



Pill Burden Elimination to Improve Adherence through Use of Fixed Dose Combinations Among HIV Positive Diabetic

Patients - Taso Uganda Experience

D. Matanda, R. Nyatia, J. BirungiHIV/AIDS, Treatment of OIS, ART and other Chronic Diseases, The AIDS Support

Organisation, Kampala, Uganda



Given Little Attention, the Views of HIV Positive Patients on Fixed Drug Combinations - Taso Uganda Experience

J. Birungi 1, C. luzze2, B.M. Etukoit 2, R. Mwesigwa 3

1 Research, 2 Planning and Strategic Information, 3 Medical, HIV Care, The AIDS Support Organisation (Taso) Uganda, Kampala, Uganda


S04 - Symposium 4

Lessons on Renoprotection in CKD patients from the New Big Combination Studies

G.L. BakrisMedicine, Hypertensive Disease Unit, The University of Chicago Prtizker School of

Medicine, Chicago, USA


S04 - Symposium 4

Raas Inhibition and Renoprotection - Are They Doing it Beyond Blood Pressure Lowering

L.M. RuilopeHypertension Unit, Hospital 12 de Octubre, Madrid, Spain



Dow



ber 2022


S04 - Symposium 4

Combination Therapy for Total Blockade of the Renin-Angiotensin-Aldosterone Blockade

A. MimranDepartment of Internal Medicine, Lapeyronie Hospital, Montpellier, France


S05 - Symposium 5

Can We Manipulate Adipose Tissue, Independent of Weight Loss, to Improve the Metabolic Syndrome?

N. SternInstitute of Endocrinology, Metabolism and Hypertension, Tel Aviv-Sourasky Medical Center

and Saccler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel


S05 - Symposium 5

Risk Factor Control in Diabetes - New Directions Based on Fixed Drug Combinations

P. NilssonClinical Sciences, Medicine, Lund University, Malmo, Sweden


S05 - Symposium 5

The Role of Aldosterone Antagonists in the Management of Obesity and the Metabolic Syndrome

S. Withers 1, C. Agabiti-Rosei 2, A. Greenstein 1, R. Aslam 1, R. Malik 1, A. Heagerty 1

1 Cardiovascular Research, University of Manchester, Manchester, UK, 2 Medical & Surgical Sciences, University of Brescia, Brescia, Italy



Dow



ber 2022


LW3 - Lunchtime Workshop 3

Blood Pressure Control in Eastern European Countries

S. TorbovaDepartment of Cardiology, University Hospital "Tokuda", Sofia, Bulgaria



Advances in The Treatment of Fixed Drug Combination in Hypertension and Hyperlipidaemia in Low and Middle Income Countries

Y. SeedatDepartment Of Medicine, Internal Medicine, University of KwaZulu Natal, Durban, South

Africa



Do We Control the Risk of Hypertension and Peripheral Artery Disease?

D. ClementUniversity Hospital, Department of the Dean, Ghent, Belgium



Current Treatment Combination Strategies in High Risk Hypertensive Patients

A. CocaHypertension Unit, Institute of Medicine and Dermatology, Hospital Clinic (IDIBAPS),

University of Barcelona, Barcelona, Spain



Dow



ber 2022



Hypertension and Atrial Fibrillation

A.J. ManolisCardiology Department, Asklepeion Hospital, Athens, Greece, Emory University, Atlanta,

GA, USA


S06 - Symposium 6

Tablet Load in Hypertensive Patients

D.G. BeeversDepartment of Medicine, City Hospital, Birmingham, United Kingdom


S06 - Symposium 6

Treatment Goals in Patients with Hypertension

K.H. RahnDepartment of Medicine, University of Muenster Medical School, Muenster, Germany


PO - Posters

Perindopril and Amiodarone as a Combined Treatment in Patients with Ischemic Heart Disease

S. Grigoryan, L. Hazarapetyan, A. StepanyanArrhythmia, Cardiology, National Institute of Health, Yerevan, Armenia



Dow



ber 2022


PO - Posters

Effect on Ambulatory Blood Pressure of a Fixed Combination of ACE Inhibitor and Calcium Channels Blocker (Dironorm) Added to Pre-existence

Antihypertensive Therapy in Uncontrolled High Risk Hypertensive Patients

D. Raev 1, T. Yanev 1, S. Torbova 2

1 Cardiology and ICU, ICU, Medical Institute, Ministry of Interior, 2 Cardiology, Hypertension Unit, Tokuda University Hospital, Sofia, Bulgaria


PO - Posters

Effect of a Fixed Combination ACE Inhibitor and Calcium Channel Blocker (Dironorm) on Central Blood Pressure and Aortic Stiffness

in Untreated Hypertensive Patients

D. Raev, A. StanevaCardiology and ICU, ICU, Medical Institute, Ministry of Interior, Sofia, Bulgaria


PO - Posters

Effect of a Fixed Combination ACE Inhibitor and Calcium Channel Blocker (Dironorm) on Endothelial Function in Untreated

Hypertensive Patients

D. Raev, I. IvanovCardiology and ICU, ICU, Medical Institute, Ministry of Interior, Sofia, Bulgaria


PO - Posters

Evaluation of the Efficacy and Tolerability of Fixed-dose Combination of Lisinopril and Amlodipine in the Treatment of Uncontrolled

High-risk Hypertensive Patients

S. Torbova 1, D. Raev 2, L. Vladimirova 3, S. Naydenov 4, G. Gentchev 5

1 Cardiology, Hypertension Unit, Tokuda University Hospital, Sofia, 2 Cardiology and ICU, Cardiology, Medical Institute, Ministry of Interior, Sofia, 3 Cardiology, Medical University, Plovdiv, 4 Internal Diseases, Cardiology, Medical University, Sofia, 5 Social Medicine and

Healthcare Management, Medical University, Sofia, Bulgaria



Dow



ber 2022


PO - Posters

Treatment Experience of Ezitimibe and Metformine at Patients with Non-Alcoholic Fatty Liver Disease

E. Egorova, L. Zvenigorodskaya, N. Melnikova, S. ChomerikiMetabolic syndrome, Gastroenterology, Central Research Institute of Gastroenterology,

Moscow, Russia


PO - Posters

Evaluation of Effectiveness in the Hypolipidemic Therapy of Patients with Atherogenic Dislipoproteinemia and Nonalcoholic Fatty Liver Disease

L. Zvenigorodskaja, E. Cherkashova, N. Samsonova, N. MelnikovaMetabolic Syndrome, Therapy, Scientific Research Institute of Gastroenterology, Moscow,

Russia


PO - Posters

Effects of Combined Metformin and Honey Supplementation on Antioxidant Enzymes and Markers of Oxidative Stress in Kidneys of

Streptozotocin-Induced Diabetic Rats

O.O. Erejuwa 1, S.A. Sulaiman 1, M.S. Ab Wahab 1, K.N.S. Sirajudeen 2, S. Salzihan 3

1 Department of Pharmacology, 2 Department of Chemical Pathology, 3 Department of Pathology, School of Medical Sciences, Universiti Sains Malaysia, Kubang Kerian,

Kelantan, Malaysia


PO - Posters

The Efficacy of a Fixed Combination Amlodipine - Valsartan in the Control of Moderate - Severe Essential Hypertension

C. Zorila 1, L. Mos 1, A. Wiener 1, A. Marian 2

1 Dept. of Internal Medicine, Western University "Vasile Goldis", 2 Dept. of Internal Medicine, Clinic Municipal Hospital, Arad, Romania



Dow



ber 2022


PO - Posters

The Kalium Balance in Elderly Hypertensive Patients Treated with Quinaprilum-Hydrochlorothiazide Combination

L. Mos 1, C. Zorila 1, A. Wiener 1, A. Marian 2

1 Internal Medicine, Western University "Vasile Goldis", 2 Internal Medicine, Clinic Municipal Hospital, Arad, Romania


PO - Posters

Clinical Characteristics in Patients with Primary Hyperlipidemias

L. Castelo 1, A. Barreto 2

1 Diabetes Mellitus, 2 General Medicine, Endocrinology, National Institute of Endocrinology, Havana, Cuba


PO - Posters

The Change of Left Ventricle Diastolic Function in the Patients with Type 2 Diabetes and Arterial Hypertension

G. Abuladze 1, N. Jinjolia 2, S. Tvaltchrelidze 3

1 Cardiovascular Disease, Arrhythmia, Institute of Cardiology, 2 Cardiology, Echo Laboratory, Angiocardiology Clinic, 3 Cardiology, Heart Catheterisation Laboratory,

Angiocardiology Clinic, Tbilisi, Georgia


PO - Posters

Fixed Dose Combination Drugs for Hypertension, Diabetes Mellitus and Dyslipidemia - How Relevant to the Nigerian Black Population?

O. Ogunleye1, S. Ogundele 1, A. Ogbera 2

1 Medicine, Clinical Pharmacology/Hypertension Clinic, 2 Medicine, Endocrinology, Lagos State University College of Medicine and Teaching Hospital, Ikeja, Lagos, Nigeria



Dow



ber 2022


PO - Posters

The Coexistence of Coronary-Pulmonary Fistula, Diabetes Mellitus and Subacute Cutaneus lupus Erythematosus , Case Study

B. Przywara 1, M. Pindycka-Piaszczynska 2, M. Paluch 1, M. Opara 1, M. Pluszczyk 1, D. Kawecki 1,J. Dola 1, M. Fudal 1, A. Tomasik 1, A. Kuczaj 1, E. Nowalany-Kozielska 1

1 Department of Cardiology, 2 Department of Internal Medicine, Dermatology and Allergology, Medical University of Silesia, Zabrze, Poland


PO - Posters

Lipid Profile Under Treatment in Diabetes

S. BistriceanuFamily Medicine, General Practice, NSFM Romania, NAPCRG, EGPRN, Botosani, Romania


PO - Posters

A Comparison of Blood Pressure and Low-Density Lipoprotein Cholesterol Reduction After Treatment With Single-Pill Amlodipine/Atorvastatin in

Elderly (75 years or more) and Younger (less than 75 years) Patients: Results of a Pooled Analysis of 5559 Patients

R. Feldman 1, J. Flack 2, R. Hobbs 3, L. Howes 4, T. Jenssen 5, R. Reeves 6, H. Shi 7,M. Westergaard 7

1 University of Western Ontario, London, Ontario, Canada, 2 Wayne State University, Detroit, Michigan, USA, 3 University of Birmingham, Birmingham, UK, 4 Gold Coast

Hospital, Southport, Queensland, Australia, 5 University of Oslo, Oslo, Norway, 6 Cardiovascular Associates PC, Birmingham, Alabama, USA, 7 Pfizer Inc, New York, NY,

USA


PO - Posters

Lipid Profile Under Treatment in Type 2 Diabetes

S. BistriceanuFamily Medicine, General Practice, NAPCRG, EGPRN, Botosani, Romania



Dow



ber 2022


PO - Posters

A Comparison of Blood Pressure and Low-Density Lipoprotein Cholesterol Reduction After Treatment With Single-Pill Amlodipine/Atorvastatin in Younger (Less Than 65 Years) and Older (65 Years or More) Men and

Women: Results of a Pooled Analysis of 5559 Patients

R. Hobbs 1, R. Feldman 2, J. Flack 3, L. Howes 4, T. Jenssen 5, R. Reeves 6, H. Shi 7,M. Westergaard 7

1 University of Birmingham, Birmingham, UK, 2 University of Western Ontario, London, Ontario, Canada, 3 Wayne State University, Detroit, Michigan, USA, 4 Gold Coast Hospital,

Southport, Queensland, Australia, 5 University of Oslo, Oslo, Norway, 6 Cardiovascular Associates PC, Birmingham, Alabama, USA, 7 Pfizer Inc, New York, NY, USA


PO - Posters

Reduction in Blood Pressure and Low-Density Lipoprotein Cholesterol When Single-Pill Amlodipine/Atorvastatin is Used as First-Line or

Add-On Treatment

J. Flack 1, R. Feldman 2, R. Hobbs 3, L. Howes 4, T. Jenssen 5, R. Reeves 6, R. Moller 7, H. Shi 7,M. Westergaard 7

1 Wayne State University, Detroit, Michigan, USA, 2 University of Western Ontario, London, Ontario, Canada, 3 University of Birmingham, Birmingham, UK, 4 Gold Coast Hospital, Southport, Queensland, Australia, 5 University of Oslo, Oslo, Norway, 6 Cardiovascular

Associates PC, Birmingham, Alabama, USA, 7 Pfizer Inc, New York, NY, USA


PO - Posters

Efficacy of the Combination of Lisinopril and Hydrochlorothiazide in Patients with Hypertension and Metabolic Syndrome Uncontrolled with

Previous Treatment

N.I. Stolyarova, E.D. Li, T.V. BoriskinaTherapy, The Bank of Russia Medical Center, Moscow, Russian Federation


PO - Posters

Dislipidemia and Arterial Hypertension in Patients with Diabetes Mellitus and Erectile Dysfunction Involve a Predominant Pro-Inflammatory Background

M.d.J. Arana Rosainz 1, M. Ojeda 1, R. Fragas Valdes 2, C.T. Garcia Alvarez 1,L. Castelo Elias-Calles 1, N. Orlandi 1, O. Torres 3, E. Maciquez 1, M. Estevez 1

1 Institute of Endocrinology, 2 Hospital Universitario "Cmdte. Manuel Fajardo", 3 Hospital Universitario "Julio Trigo", La Habana, Cuba



Dow



ber 2022


PO - Posters

Telmisartan in Combination with Amlodipine Provides a Highly Effective and Well Tolerated Treatment Option for Hypertensive Patients

with Diabetes: Sub-Analysis from a Factorial Design Study

T. Littlejohn 1, L. Ruilope2, P. Raskin 3, J. Neutel 4, C. Majul 5, W. Oigman 6, R. Olvera 7,M. Seeber 8, M. Kobe 9, H. Schumacher 10

1 Piedmont Medical Research Associates, USA, 2 Unidad de Hipertension, Madrid, Spain, 3 University of Texas, Southwestern Medical Center, USA, 4 Orange County Research

Center, USA, 5 Hospital Santojanni, Argentina, 6 Rio de Janeiro State University, Brasil, 7 Clinica de Estudios Medicos SC, Mexico, 8 Medi-Clinic Heart Hospital, South Africa,

9 Boehringer Ingelheim Inc, USA, 10 Boehringer Ingelheim GmbH, Germany


PO - Posters

Combination of Telmisartan with Amlodipine Provides an Effective Treatment Option for Elderly Patients:

Sub-Analysis from a Factorial Design Study

T. Littlejohn 1 , B. Dahlöf 2, S. Chrysant 3, J. Neutel 4, C. Majul 5, W. Oigman 6, R. Olvera 7,M. Seeber 8, M. Kobe 9, H. Schumacher 10

1 Piedmont Medical Research Associates, USA, 2 Sahlgrenska University Hospital, Göteborg, Sweden Oklahoma CV and Hypertension Center, USA

4

3

Research Center, USA, 5 Hospital Santojanni, Argentina, 6 Rio de Janeiro State University, Brasil, 7 Clinica de Estudios Medicos SC, Mexico, 8 Medi-Clinic Heart Hospital, South

Africa, 9 Boehringer Ingelheim Inc, USA, 10 Boehringer Ingelheim GmbH, Germany


PO - Posters

Telmisartan and Amlodipine in Combination are Effective at Lowering 24-Hour BP in Elderly Hypertensive

Patients and Those With Elevated SBP: Findings of an ABPM Sub-Study

T. Littlejohn 1, G. Mancia 2, R. Christensen 3, R. Guthrie 4, C. Majul 5, W. Oigman 6, R. Olvera 7,M. Seeber 8, M. Kobe 9, H. Schumacher 10

1 Piedmont Medical Research Associates, USA, 2 University Milano-Bicocca, San Gerardo Hospital, Monza-Milan, Italy, 3 J Lewis Research Inc, USA, 4 Ohio State University, USA,

5 Hospital Santojanni, Argentina, 6 Rio de Janeiro State University, Brasil, 7 Clinica de Estudios Medicos SC, Mexico, 8 Medi-Clinic Heart Hospital, South Africa, 9 Boehringer

Ingelheim Inc, USA, 10 Boehringer Ingelheim GmbH, Germany


PO - Posters

Telmisartan and Amlodipine in Combination are Effective at Lowering24-Hour BP in Diabetic and Obese Hypertensive Patients:

Findings of an ABPM Sub-Study

T. Littlejohn 1, G. Mancia 2, R. Guthrie 3, R. Marple 4, C. Majul 5, W. Oigman 6, R. Olvera 7,M. Seeber 8, M. Kobe 9, H. Schumacher 10

1 Piedmont Medical Research Associates, USA, 2 University Milano-Bicocca, San Gerardo Hospital, Monza-Milan, Italy, 3 Ohio State University, USA, 4 Castlerock Clinical Research, USA, 5 Hospital Santojanni, Argentina, 6 Rio de Janeiro State University, Brasil, 7 Clinica de Estudios Medicos SC, Mexico, 8 Medi-Clinic Heart Hospital, South Africa, 9 Boehringer

Ingelheim Inc, USA, 10 Boehringer Ingelheim GmbH, Germany



Dow



ber 2022


PO - Posters

Efficacy of Telmisartan in Combination with Amlodipine in Obese Hypertensive Patients: Sub-Analysis from a Factorial Design Study

T. Littlejohn 1, L. Ruilope 2, S. Chrysant 3, D. Webster 4, C. Majul 5, W. Oigman 6, R. Olvera 7,M. Seeber 8, M. Kobe 9, H. Schumacher 10

1 Piedmont Medical Research Associates, USA, 2 Unidad de Hipertension, Madrid, Spain, 3 Oklahoma Cardiovascular & Hypertension Center, USA, 4 TEAM Research of Central Texas, USA, 5 Hospital Santojanni, Argentina, 6 Rio de Janeiro State University, Brasil, 7 Clinica de Estudios Medicos SC, Mexico, 8 Medi-Clinic Heart Hospital, South Africa,

9 Boehringer Ingelheim Inc, USA, 10 Boehringer Ingelheim GmbH, Germany


PO - Posters

Telmisartan and Amlodipine in Combination Provide an Effective Treatment Option for Patients with Elevated Systolic BP:

Sub-Analysis from a Factorial Design Study

T. Littlejohn 1, B. Dahlöf 2, S. Chrysant 3, J. Neutel 4, C. Majul 5, W. Oigman 6, R. Olvera 7,M. Seeber 8, M. Kobe 9, H. Schumacher 10

1 Piedmont Medical Research Associates, USA, 2 Sahlgrenska University Hospital, Göteborg, Sweden, 3 Oklahoma CV and Hypertension Center, USA, 4 Orange County

Research Center, USA, 5 Hospital Santojanni, Argentina, 6 Rio de Janeiro State University, Brasil, 7 Clinica de Estudios Medicos SC, Mexico, 8 Medi-Clinic Heart Hospital, South

Africa, 9 Boehringer Ingelheim Inc, USA, 10 Boehringer Ingelheim GmbH, Germany


PO - Posters

Fixed-Dose Combination Therapy with Telmisartan and Amlodipine 5 Mg in Non-Responders to Amlodipine 5 Mg Provides Superior

Blood Pressure Reductions to, and is Better Tolerated than, Amlodipine 10 Mg

S. Neldam1, M. Lang 2

1Rødovre Centrum, Rødovre , Denmark, 2 Boehringer Ingelheim bv, Alkmaar, The Netherlands


PO - Posters

The Effect of Admission-Time Blood Sugar (BS) on the Intra Hospital Death of AMI Patients

Y. Fekri 1, N. Sepasi 2, A. Adib 3, E. Rezaei Ghalechi 1, H.R. Vahabzadeh Monshie 4, M. Didehdar 5,M. D.Nuzhdin 6

1 Public Medicine, 2 Nursing, 3 Cardiovascular Disease, Cardiac Rehabilitation, Sabalan Hospital, Ardabil, 4 Public Medicine, Cardiac Rehabilitation, Sabalan Hospital, Tehran,

5 Psychology, Cardiac Rehabilitation, Sabalan Hospital, Ardabil, Iran, 6 Public Medicine, Cardiac Rehabilitation, Chelyabinsk Hospital, Chelyabinsk, Russia



Dow



ber 2022


PO - Posters

Assessment of Pregnancy Hypertension Frequency and its Related Factors in Pregnant Women

N. Sepasi 1, Y. Fekri 2, L. Khodapanahi 3, E. Rezaei Ghalechi 2, M. Didehdar 4

1 Nursing Graduate, 2 Public Medicine, 3 Gynecologic Disease, 4 Psychology, Cardiac Rehabilitation, Sabalan Hospital, Ardabil, Iran


PO - Posters

Therapeutic Potential of Dietary Phase 2 Enzyme Inducer in Hypertension

A. Banigesh, V. Senanyake, L. Wu, P. Lee, K. Desai, B. JuurlinkPharmacology, Cardiovascular Disease, University of Saskatchewan, Saskatoon, Canada


PO - Posters

A Survey on Hypertension and Related Chronic Diseases in Anhui Province, the Middle Area of China

S. Hu 1,2, L. Wu 2, X. Fang 3, S. Jin 3, W. Xu 4, Y. Chen 2, T. Xu 3, W. Yang 2, G. Shen 1

1 Anhui Geriatric Institute, Geriatric Cardiovasular Disease, Clinical Nutrition, 2 Anhui EBM Center, 3 Anhui Geriatric Institute, 4 Pharmacy, Anhui Provincial Hospital, Hefei, P.R.

China


PO - Posters

Hypertension Prevalence, Awareness, Treatment, and Control in Yazd, Iran

Z. Kalani 1, H. Abdi 1, L. Shahbazi 1, T. Salimi 1, M.R. Aminipour 2, P. Pourmovahed 3

1 Nursing and Midwifery Faculty, Nursing, Yazd University of Medical Science and Health Services, 2 Health Faculty, Occupational health, Yazd University of Medical Science and

Health Services, 3 Graphic, Technical School, Yazd, Iran



Dow



ber 2022

To access Hypertension Aff ects Everyone visitwww.nature.com/hypertension

Hypertension Aff ects Everyone features research highlighting the causes of hypertension and how it aff ects children, adults and the elderly. Th is online special provides you with FREE online access to select articles from: American Journal of HypertensionHypertension ResearchJournal of Human Hypertension

*World Heart Federation. 2009. Cardiovascular disease risk factors – hypertension. Available at: http://www.world-heart-federation.org/cardiovascular-health/cardiovascular-disease-risk-factors/hypertension/#c560. Accessed June 9, 2009.** Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet 2005; 365:217-223.

Articles include:

Cognitive dysfunction and physical disability are associated with mortality in extremely elderly patientsS Hoshide, J Ishikawa, K Eguchi, et al.

Prevalence and predictors of masked hypertension detected by home blood pressure monitoring in children and adolescents: Th e Arsakeion School StudyG S Stergiou, V C Rarra and N G Yiannes

Hypertensive women with the metabolic syndrome are at risk of renal insuffi ciency more than men in general populationP Korhonen, P Aarnio, R Vesalainen, et al.

FACT: At least 970 million people are aff ected by hypertension worldwide.*PREDICTION: By 2025 1.56 billion individuals will have hypertension.* *

Hypertension Aff ects EveryoneOnline Special

21343-09_HypertensionAffectsEveryone_RJPFAC.indd 121343-09_HypertensionAffectsEveryone_RJPFAC.indd 1 29/6/09 15:00:3129/6/09 15:00:31

Dow



ber 2022

In an eff ort to enhance communication of knowledge about research and practice in hypertension and its related conditions in their two scientifi c communities, the American Journal of Hypertension (AJH) and the Chinese Journal of Hypertension (CJH) have partnered to exchange valuable published research.

Starting in September, AJH will feature 2-3 abstracts from the Chinese Journal of Hypertension in a new section entitled CJH Abstracts.

In celebration of this new partnership, the September issue of AJH also reports on the “International Workshop of Dietary Sodium and Human Health in China and the United States”. Dr. Bruce Neal serves as Guest Editor of proceedings from the Workshop.

Proceedings Articles Featured in the September Issue:

• The Dietary Sodium and the Incidence of Hypertension in Chinese Population – a Review ofNation-wide Surveys | Zhiquan Liu

• Compound Ion Salt, a Novel Low Sodium Salt Substitute: from Animal Study to Community-Based Population Trial | Xin Zhou

• Family Based Randomized Trial to Detect Blood Eff ects of a Salt Substitute Controlling Potassium and Calcium in Hypertensive Adolescents | Jianjun Mu

www.nature.com/ajh

21479-06 AJH Chinese issue RJFP4C.indd 121479-06 AJH Chinese issue RJFP4C.indd 1 4/8/09 11:30:084/8/09 11:30:08

Dow



ber 2022

The American Journal of Hypertension 1

Documents

Transcript of The American Journal of Hypertension 1